All Resources

Antibody Discovery

Webinar: Tackle Difficult Targets by Accessing Broad B Cell Diversity

Watch our presentation at AE&T Digital Week, hosted with Genovac, to hear how the Beacon system is making it possible to find 10 times more lead candidates than hybridoma in just days.

Antibody Discovery

Webinar: A Beacon for Rapid Antibody Discovery against Difficult Targets

Panelists from Genovac, will present case studies of how they have leveraged their core genetic immunization technology and the Beacon optofluidic system to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species.

Cell Therapy Development

Datasheet: The Opto™ Antigen Presenting Bead Kit

Learn more about the Opto™ Antigen Presenting Bead (Opto™ APB) Kit, its key applications, and how it benefits your cell therapy development workflows by efficiently expanding more antigen-specific T cells than dendritic cells.

Cell Therapy Development

Application Note: Unravel the Complexity of Single Natural Killer Cell Cytotoxicity and ADCC Mediation

Explore how the Cytotoxicity Assay can be used to characterize and better understand NK cells in the pursuit of more efficacious cell therapies.

Antibody Discovery

Application Note: Rapid High-Resolution Screening of Plasma B Cells to Identify Antibody Lead Candidates

Explore case studies for the rapid discovery of antibodies against challenging targets.

Cell Therapy Development

Brochure: Cell Therapy Development

From expanding rare, antigen-specific T cells to fully characterizing them, learn how our capabilities are making cell therapy development more efficient.

Antibody Discovery

Customer Spotlight: Abveris on Antibody Discovery

Find out how Abveris is transforming their antibody discovery processes with the Beacon® optofluidic system.

Beacon System

Brochure: Beacon System

Discover how the Beacon system shortens timelines, simplifies workflows and reveals detailed data through deep profiling.

Cell Therapy Development

Application Note: Multidimensional Analysis of T Cell Cytotoxicity and Serial Killing Using the Opto™ Cell Therapy Development Workflow

Learn how to use multiple assays on single T cells to finally understand critical functions, such as serial killing, and how they relate to each other.

Cell Therapy Development

Application Note: Identify and Select Optimal CAR T Cell Phenotypes with the Opto™ Cell Therapy Development Workflow

Learn how to combine the T Cell Proliferation Assay with either the Multiplex Cytokine Assay or Cytotoxicity Assay to find your most persistent T cells.

Antibody Discovery Cell Line Development

Customer Spotlight: Amgen on AbD and CLD

Find out how Amgen is transforming their antibody discovery and clonal cell line processes with the Berkeley Lights Platform.

Cell Line Development

Fireside Chat: Every Day Matters – Optimizing COVID-19 Therapies for Manufacturing

Dr. James Rothman, Nobel Laureate hosts an in-depth discussion with distinguished guests, Dr. Jennitte Stevens from Amgen, Dr. Gregory Bleck from Catalent-Biologics, and Dr. Trent Munro from the University of Queensland on fast-tracking the development of therapeutic antibodies and vaccines for SARS-CoV-2.

Cell Therapy Development

Webinar: Expand and Rapidly Validate Antigen-Specific Function of T Cells Using Fewer Cells

Yelena Bronevetsky, PhD, lays out the current challenges in tumor antigen discovery and how our Opto™ Antigen Presenting Bead Kit helps scientists overcome them.

Antibody Discovery

Application Note: Rapid Discovery of Therapeutic Antibodies for the SARS-CoV-2 Pandemic Virus Using the Opto Viral Neutralization 1.0 Workflow

Learn how to use blocking and binding assays and the Opto Viral Neutralization 1.0 workflow to identify cross-reactive antibodies that may have broad neutralization capacity across the coronavirus family.

Cell Line Development

Customer Spotlight: Catalent on CLD

Find out how Catalent Biologics is able to select significantly higher expressing clonal cell lines with the Opto CLD workflow.

Cell Therapy Development

Product Tour: The Opto™ Cell Therapy Development Workflow

Guided by T cell expert, Yelena Bronevetsky, PhD, get a deeper look at how the Opto™ Cell Therapy Development workflow can be used to validate, expand, and fully characterize over a 1,000 T cells.

Cell Therapy Development Lightning System

Brochure: Lightning System

Find out how the Lightning platform lets you visualize diverse cell interactions, measure individual cell cytotoxicity, and recover cells of interest alive.

Antibody Discovery

Webinar: Rapid Discovery of a Diverse Panel of Antibodies Against Membrane Targets Using the Beacon System

Dr. Shireen Khan presents a case study on how ChemPartner has leveraged the Beacon system to rapidly discover cross-reactive antibodies against the GPI-anchored uPA receptor.